Annual EBITDA
-$30.21M$73.79M+70.95%
Summary
- Current Value
- As of today, PHR annual EBITDA is -$30.21M, up +70.95% on
- Historical Performance
- PHR annual EBITDA is up +68.37% over the past 3 years, and down -491.68% over the past 5 years
- All-Time High Comparison
- PHR annual EBITDA is currently -1538.62% below its historical high of $2.10M set on
- 3-Year Low Comparison
- PHR annual EBITDA is +79.72% above its 3-year low of -$148.95M reached on an earlier date
- Sector Comparison
- PHR annual EBITDA is higher than 39.83% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$30.21M | +71.0% | +68.4% | -491.7% | -514.9% | |
| Quarterly EBITDA | $11.22M | +306.4% | +134.8% | +1062.8% | +458.9% | |
| TTM EBITDA | $20.38M | +141.7% | +113.2% | +753.9% | +752.2% | |
| Price | $17.52 | -35.1% | -44.0% | -69.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $419.81M | +17.8% | +96.9% | +236.4% | +425.9% | |
| Annual EPS | -$1.02 | +59.5% | +57.1% | +58.3% | +1.8% | |
| Annual EBIT | -$58.10M | +56.5% | +50.3% | -205.3% | -299.2% | |
| Annual Net Income | -$58.53M | +57.2% | +50.5% | -188.4% | -53.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$30.21M | at high | |
| 5Y | -$5.11M | N/A | -491.7% |
| All | $2.10M | -1538.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$148.95M | N/A | +79.7% |
| 5Y | -$148.95M | +79.7% | |
| All | -$148.95M | +79.7% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$30.21M | +71.0% | |
| -$104.00M | +30.2% | |
| -$148.95M | -55.9% | |
| -$95.51M | -890.8% |
| Year | Value | Change |
|---|---|---|
| -$9.64M | -88.8% | |
| -$5.11M | -343.1% | |
| $2.10M | +142.7% | |
| -$4.91M | - |
FAQ
What is the current annual EBITDA of PHR?
As of today, PHR annual EBITDA is -$30.21M
What is 1-year change in PHR annual EBITDA?
PHR annual EBITDA is up +70.95% year-over-year
What is 3-year change in PHR annual EBITDA?
PHR annual EBITDA is up +68.37% over the past 3 years
How far is PHR annual EBITDA from its all-time high?
PHR annual EBITDA is currently -1538.62% below its historical high of $2.10M set on January 31, 2019
How does PHR annual EBITDA rank versus sector peers?
PHR annual EBITDA is higher than 39.83% of companies in Healthcare sector
When is PHR next annual earnings release?
The next annual earnings release for PHR is on
Quarterly EBITDA
$11.22M$5.07M+82.57%
Summary
- Current Value
- As of today, PHR quarterly EBITDA is $11.22M, up +82.57% on
- Historical Performance
- PHR quarterly EBITDA is up +306.42% year-over-year, and up +134.84% over the past 3 years
- All-Time High Comparison
- PHR quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PHR quarterly EBITDA is +134.74% above its 3-year low of -$32.29M reached on
- Sector Comparison
- PHR quarterly EBITDA is higher than 78.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $11.22M | +82.6% | +306.4% | +134.8% | +1062.8% | |
| Annual EBITDA | -$30.21M | – | +71.0% | +68.4% | -491.7% | |
| TTM EBITDA | $20.38M | +446.3% | +141.7% | +113.2% | +753.9% | |
| Price | $17.52 | -25.2% | -35.1% | -44.0% | -69.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $120.33M | +2.6% | +12.7% | +64.6% | +212.8% | |
| Quarterly EPS | $0.07 | +554.7% | +127.9% | +109.1% | +139.8% | |
| Quarterly EBIT | $3.74M | +348.1% | +127.0% | +109.4% | +161.2% | |
| Quarterly Net Income | $4.27M | +553.1% | +129.7% | +110.6% | +163.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $11.22M | at high | |
| 3Y | $11.22M | at high | |
| 5Y | $11.22M | at high | |
| All | $11.22M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$5.43M | N/A | +306.4% |
| 3Y | -$32.29M | +134.7% | |
| 5Y | -$44.24M | +125.3% | |
| All | -$44.24M | +125.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PHR?
As of today, PHR quarterly EBITDA is $11.22M
What is PHR quarterly EBITDA most recent change?
PHR quarterly EBITDA was up +82.57% on October 31, 2025
What is 1-year change in PHR quarterly EBITDA?
PHR quarterly EBITDA is up +306.42% year-over-year
How far is PHR quarterly EBITDA from its all-time high?
PHR quarterly EBITDA is currently at its all-time high
How does PHR quarterly EBITDA rank versus sector peers?
PHR quarterly EBITDA is higher than 78.61% of companies in Healthcare sector
When is PHR next earnings release?
The next earnings release for PHR is on
TTM EBITDA
$20.38M$16.65M+446.29%
Summary
- Current Value
- As of today, PHR TTM EBITDA is $20.38M, up +446.29% on
- Historical Performance
- PHR TTM EBITDA is up +141.72% year-over-year, and up +113.15% over the past 3 years
- All-Time High Comparison
- PHR TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PHR TTM EBITDA is +113.15% above its 3-year low of -$155.01M reached on an earlier date
- Sector Comparison
- PHR TTM EBITDA is higher than 77.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $20.38M | +446.3% | +141.7% | +113.2% | +753.9% | |
| Annual EBITDA | -$30.21M | – | +71.0% | +68.4% | -491.7% | |
| Quarterly EBITDA | $11.22M | +82.6% | +306.4% | +134.8% | +1062.8% | |
| Price | $17.52 | -25.2% | -35.1% | -44.0% | -69.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $463.21M | +3.0% | +14.3% | +76.6% | +231.6% | |
| TTM EPS | -$0.10 | +76.8% | +93.5% | +97.3% | +84.2% | |
| TTM EBIT | -$8.67M | +67.0% | +89.2% | +95.3% | +60.7% | |
| TTM Net Income | -$5.38M | +77.6% | +93.5% | +97.1% | +76.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $20.38M | at high | |
| 3Y | $20.38M | at high | |
| 5Y | $20.38M | at high | |
| All | $20.38M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$48.85M | N/A | +141.7% |
| 3Y | -$155.01M | N/A | +113.2% |
| 5Y | -$155.01M | +113.2% | |
| All | -$155.01M | +113.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PHR?
As of today, PHR TTM EBITDA is $20.38M
What is PHR TTM EBITDA most recent change?
PHR TTM EBITDA was up +446.29% on October 31, 2025
What is 1-year change in PHR TTM EBITDA?
PHR TTM EBITDA is up +141.72% year-over-year
How far is PHR TTM EBITDA from its all-time high?
PHR TTM EBITDA is currently at its all-time high
How does PHR TTM EBITDA rank versus sector peers?
PHR TTM EBITDA is higher than 77.89% of companies in Healthcare sector
When is PHR next earnings release?
The next earnings release for PHR is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- PHR Official Website www.phreesia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1412408/000141240825000114/0001412408-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1412408/000141240825000010/0001412408-25-000010-index.htm
- PHR Profile on Yahoo Finance finance.yahoo.com/quote/PHR
- PHR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/phr